LRA Brings Encouraging News from European Rheumatology Meeting News Update June 2, 2022 The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS)...
Lupus Research Alliance Applauds U.S. FDA Approval of AstraZeneca’s anifrolumab-fnia (Saphnelo™) for Systemic Lupus Erythematosus (SLE) Press Release First in New Class of Drugs in More than a Decade for SLE Targeting Type 1 Interferons NEW YORK, NY....
